Vista Pharmaceuticals Ltd

As of 19-Nov, Vista Pharmaceuticals Ltd is seeing a price increase to Rs 9.18, up 20.0%, but remains below key moving averages and has experienced a 25.71% drop in delivery volume. Despite today's gains, the stock has underperformed against the Sensex over various periods, indicating ongoing challenges in attracting investor confidence.

As of 18-Nov, Vista Pharmaceuticals Ltd's stock price is Rs. 8.00, down 4.65%, and has reached a 52-week low of Rs. 7.63. The stock has significantly underperformed its sector and the benchmark Sensex, indicating a bearish trend and lack of investor confidence.

As of 17-Nov, Vista Pharmaceuticals Ltd's stock price is Rs. 8.39, down 10.93%, hitting a new 52-week low. The stock has significantly underperformed its sector and the broader market, with a year-to-date decline of 28.78%, despite increased delivery volume indicating higher investor participation.

Vista Pharma has experienced declining financial performance, with net sales dropping from 31.07 Cr in March 2019 to 10.07 Cr in March 2025, and consistent losses reflected in negative operating profits and increasing total liabilities. The company has struggled with cash flow from operations, indicating ongoing financial challenges.

Vista Pharma has experienced significant financial challenges, with declining net sales from 31.07 Cr in Mar'19 to 10.07 Cr in Mar'25, and negative operating profits since Mar'20. Despite an increase in total assets and a reduction in debt, the company has struggled with profitability and operational efficiency.

As of 11-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase to 9.84, reflecting a 2.5% upward change. The stock has shown short-term bullish sentiment, outperforming its sector today, despite longer-term declines.

As of 27-Oct, Vista Pharmaceuticals Ltd is seeing a short-term price increase to 10.09, but has a mixed long-term performance with a year-to-date drop of 14.35%. Despite outperforming the Sensex recently, the significant decrease in investor participation suggests potential challenges ahead.

As of 13-Oct, Vista Pharmaceuticals Ltd's stock price is Rs 9.57, down 3.43%, and has fallen 6.45% over the last two days. The stock is underperforming compared to the Sensex, trading below key moving averages and nearing its 52-week low, with a significant drop in investor participation.

As of 09-Oct, Vista Pharmaceuticals Ltd's stock price is at 10.23, up 3.86% over the last two days, but it has underperformed year-to-date and over the past year with declines of 13.16% and 20.64%, respectively. Despite recent gains, the stock remains below its 100-day and 200-day moving averages, indicating ongoing challenges.

As of 29-Sep, Vista Pharmaceuticals Ltd's stock price is declining at 9.62, down 6.05%, and has underperformed its sector and the Sensex. The company faces weak fundamentals, significant drops in investor participation, and a poor EBIT to interest ratio, indicating ongoing financial struggles.

As of 26-Sep, Vista Pharmaceuticals Ltd is currently priced at 10.24, reflecting a short-term gain despite a year-to-date decline of 13.07% and a 26.86% drop over the past year, indicating ongoing fundamental weaknesses. The stock has recently outperformed its sector, but long-term challenges remain due to operating losses and poor growth metrics.

As of 24-Sep, Vista Pharmaceuticals Ltd is priced at 9.71, showing a slight increase but remains below its moving averages, indicating a bearish trend. The stock has significantly underperformed over the past year and faces operational challenges, leading to its classification as a strong sell despite some short-term resilience.

As of 23-Sep, Vista Pharmaceuticals Ltd's stock price is Rs 9.51, down 3.45%, with significant underperformance reflected in a 1-week return of -4.42% and a 1-month return of -7.67%. The company faces operational challenges and has consistently underperformed against market benchmarks, indicating a bearish trend and weak financial health.